Literature DB >> 27790852

Syndecans - key regulators of cell signaling and biological functions.

Nikolaos A Afratis1,2, Dragana Nikitovic3, Hinke A B Multhaupt2, Achilleas D Theocharis1, John R Couchman2, Nikos K Karamanos1.   

Abstract

Syndecans are a small family of four transmembrane proteoglycans in mammals. They have similar structural organization, consisting of an N-terminal ectodomain, single transmembrane domain and C-terminal cytoplasmic domain. Over the years, the association between syndecans and the actin cytoskeleton has been established, which has consequences for the regulation of cell adhesion and migration. Specifically, ecto- and cytoplasmic domains are responsible for the interaction with extracellular matrix molecules and intracellular kinases, respectively. These interactions indicate syndecans as key molecules during cancer initiation and progression. Particularly syndecans interact with other cell surface receptors, such as growth factor receptors and integrins, which lead to activation of downstream signaling pathways, which are critical for the cellular behavior. Moreover, this review describes the key role of syndecans in intracellular calcium regulation and homeostasis. The syndecan-mediated regulation of calcium metabolism is highly correlated with cells' adhesion phenotype through the actin cytoskeleton and formation of junctions, with implications during differentiation and disease progression.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  cell adhesion; growth factor receptors; growth factors; integrins; migration; signaling; syndecans

Mesh:

Substances:

Year:  2016        PMID: 27790852     DOI: 10.1111/febs.13940

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  80 in total

Review 1.  Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights.

Authors:  Venkat Raghavan Krishnaswamy; Amit Benbenishty; Pablo Blinder; Irit Sagi
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

Review 2.  Soluble syndecans: biomarkers for diseases and therapeutic options.

Authors:  Jessica Bertrand; Miriam Bollmann
Journal:  Br J Pharmacol       Date:  2018-07-23       Impact factor: 8.739

3.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

4.  Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.

Authors:  Bohee Jang; Hyejung Jung; Sojoong Choi; Young Hun Lee; Seung-Taek Lee; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2017-08-16       Impact factor: 5.157

Review 5.  Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.

Authors:  Solomon A Agere; Eugene Y Kim; Nahid Akhtar; Salahuddin Ahmed
Journal:  J Cell Physiol       Date:  2018-03-25       Impact factor: 6.384

Review 6.  Emerging Role of Syndecans in Extracellular Matrix Remodeling in Cancer.

Authors:  Bohee Jang; Ayoung Kim; Jisun Hwang; Hyun-Kuk Song; Yunjeon Kim; Eok-Soo Oh
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

Review 7.  Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.

Authors:  Liliana Schaefer; Claudia Tredup; Maria A Gubbiotti; Renato V Iozzo
Journal:  FEBS J       Date:  2016-12-07       Impact factor: 5.542

8.  Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants.

Authors:  Ferdous Anower-E-Khuda; Gagandeep Singh; Yiping Deng; Philip L S M Gordts; Jeffrey D Esko
Journal:  Glycobiology       Date:  2019-07-19       Impact factor: 4.313

Review 9.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

10.  Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway.

Authors:  Zhihui Lu; Nana Song; Bo Shen; XiaLian Xu; Yi Fang; Yiqin Shi; Yichun Ning; Jiachang Hu; Yan Dai; Xiaoqiang Ding; Jianzhou Zou; Jie Teng
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.